XML 44 R37.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Nature of Operations and Liquidity - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended
Oct. 30, 2023
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Organization And Nature Of Operations [Line Items]        
Net income   $ 9,935 $ 4,217  
Net cash provided by operating activities   2,884 $ 10,417  
Accumulated deficit   78,006   $ 85,538
Cash and cash equivalents   $ 29,785   $ 33,509
Gyre | Gyre Pharmaceuticals        
Organization And Nature Of Operations [Line Items]        
Minority interest ownership indirectly holds 65.20%